DaVita Exceeds Q1 2026 Earnings Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy DVA?
Source: seekingalpha
- Financial Performance Surpasses Expectations: DaVita reported an adjusted operating income of $482 million for Q1, exceeding forecasts by approximately $50 million, demonstrating balanced outperformance across treatment volume, revenue per treatment, and cost management, which enhances market confidence.
- Guidance Raised for the Year: The management has raised its 2026 adjusted operating income guidance to a range of $2.15 billion to $2.25 billion, primarily driven by higher treatment volume expectations and lower patient care costs, reflecting confidence in future growth.
- Ongoing Technology Investment: The introduction of the new tool, 'ScheduleHub', which dynamically processes patient and teammate availability to optimize scheduling in real-time, indicates the company's continued investment in AI and technological infrastructure aimed at improving operational efficiency.
- Cautious on ACA Impact: While the ACA open enrollment is trending slightly favorable, management warned that an increase in patients selecting lower-tier bronze plans could lead to a modest decline in revenue per treatment, highlighting uncertainties regarding future income.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DVA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DVA
Wall Street analysts forecast DVA stock price to rise
5 Analyst Rating
1 Buy
3 Hold
1 Sell
Hold
Current: 154.080
Low
144.00
Averages
162.50
High
190.00
Current: 154.080
Low
144.00
Averages
162.50
High
190.00
About DVA
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Financial Performance Surpasses Expectations: DaVita reported an adjusted operating income of $482 million for Q1, exceeding forecasts by approximately $50 million, demonstrating balanced outperformance across treatment volume, revenue per treatment, and cost management, which enhances market confidence.
- Guidance Raised for the Year: The management has raised its 2026 adjusted operating income guidance to a range of $2.15 billion to $2.25 billion, primarily driven by higher treatment volume expectations and lower patient care costs, reflecting confidence in future growth.
- Ongoing Technology Investment: The introduction of the new tool, 'ScheduleHub', which dynamically processes patient and teammate availability to optimize scheduling in real-time, indicates the company's continued investment in AI and technological infrastructure aimed at improving operational efficiency.
- Cautious on ACA Impact: While the ACA open enrollment is trending slightly favorable, management warned that an increase in patients selecting lower-tier bronze plans could lead to a modest decline in revenue per treatment, highlighting uncertainties regarding future income.
See More
- AMD Earnings Beat: AMD's strong second-quarter revenue guidance of $11.2 billion, with a $300 million variance, surpasses analyst expectations of $10.52 billion, indicating robust demand and growth potential in the semiconductor market.
- Super Micro Profit Expectations: Super Micro Computer's stock surged 19% as fourth-quarter profit expectations range from 65 to 79 cents per share, significantly exceeding Wall Street's forecast of 55 cents, with third-quarter adjusted earnings of 84 cents showcasing its competitive edge in the server market.
- Jacobs Solutions Guidance Raised: Jacobs Solutions' shares fell 2% despite beating second-quarter adjusted earnings and revenue expectations, as the company raised its full-year earnings guidance to between $7.10 and $7.35 per share, reflecting business resilience.
- Lucid Group Misses Estimates: Lucid Group's stock dropped 2% after reporting a first-quarter loss of $3.46 per share, significantly worse than the expected $2.64 loss, with revenue of $282.5 million falling short of the $440.4 million forecast, highlighting challenges in the electric vehicle market.
See More
- Leadership Change: Warren Buffett's resignation as CEO marks a significant shift for Berkshire Hathaway, with new CEO Greg Abel taking the helm for the first time in sixty years, potentially impacting the company's investment strategy and market confidence.
- Portfolio Adjustment: Abel has reportedly sold all stocks managed by former investment lieutenant Todd Combs, amounting to approximately $15 billion, indicating a decisive move by the new CEO that may lead to a shift in the company's investment style.
- Core Holdings Strategy: In his letter to shareholders, Abel identified nine 'core holdings' that he implied would see limited activity unless there are fundamental changes in their long-term economic prospects, suggesting a potential reduction in Berkshire's investment activity.
- Market Reaction Anticipation: Investors will gain insights into Berkshire's stock transactions for Q1 in the upcoming 10-Q filing due by May 2, which will provide crucial clues about Abel's future investment direction, although it may take several quarters to fully divest Combs' investments.
See More
- Executive Shift Impact: Todd Combs, one of Buffett's top investment managers, has left for JPMorgan Chase, resulting in new CEO Greg Abel taking control of most of the portfolio, potentially affecting around $15 billion in asset allocation, reflecting significant changes in the company's governance structure.
- Portfolio Scale: Berkshire's total investment portfolio is approximately $322 billion, with Combs managing over 5% of it, equating to at least $16 billion, highlighting his importance in the company's investment strategy.
- Investment Strategy Shift: In his letter to shareholders, Abel indicated a commitment to maintaining core holdings, suggesting a potential shift towards a more passive investment strategy with fewer quarterly changes, which may alter investor expectations regarding the company's activity level.
- Market Reaction Expectations: While Abel stated that Ted Weschler would continue managing 6% of the portfolio, market uncertainty remains regarding Berkshire's future investment direction, prompting investors to closely monitor the upcoming first-quarter 10-Q report for more insights.
See More
- Leadership Transition: Warren Buffett retired on December 31, 2025, with Greg Abel stepping in to manage Berkshire Hathaway's $320 billion investment portfolio, marking a significant new era for the company.
- Investment Concentration: Abel's portfolio is heavily weighted, with 10 core holdings accounting for nearly 79% of assets, including Apple at $60 billion, highlighting the company's focus on high-quality assets and long-term growth potential.
- Sustainable Competitive Advantages: Among the 20 billion-dollar investments Abel oversees, many companies like Visa and Sirius XM operate as legal monopolies, ensuring stable revenue streams and risk resilience, reflecting Berkshire's investment strategy.
- Smaller Holdings Adjustment: Abel also manages 18 relatively smaller investments, with significant reductions like the 77% cut in Amazon's stake, indicating a focus on optimizing the portfolio and potentially paving the way for future trading opportunities.
See More
- Leadership Transition: Warren Buffett retired as CEO on December 31, 2025, with Greg Abel taking over the management of a $320 billion investment portfolio, marking a new era for Berkshire Hathaway, although Buffett remains as chairman of the board.
- Investment Philosophy Continuity: Abel shares a similar investment philosophy with Buffett, emphasizing value investing and sustainable competitive advantages, particularly by allocating a significant portion of the company's capital to their best ideas.
- Core Holdings Concentration: The ten core positions account for nearly 79% of Berkshire's invested assets, all of which pay dividends and engage in share repurchases, demonstrating strong capital return capabilities, with Abel's management style reflected in these choices.
- Smaller Investment Dynamics: Abel oversees 18 smaller holdings ranging from $5 million to approximately $692 million, many of which are being reduced or removed from the portfolio, indicating a dynamic adjustment strategy in response to market conditions.
See More











